Cargando…
Therapeutic cell engineering using surface-conjugated synthetic nanoparticles
A major limitation of cell therapies is the rapid decline in viability and function of transplanted cells. Here we describe a strategy to enhance cell therapy via the conjugation of adjuvant drug-loaded nanoparticles to the surfaces of therapeutic cells. Using this method to provide sustained pseudo...
Autores principales: | Stephan, Matthias T., Moon, James J., Um, Soong Ho, Bershteyn, Anna, Irvine, Darrell J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935928/ https://www.ncbi.nlm.nih.gov/pubmed/20711198 http://dx.doi.org/10.1038/nm.2198 |
Ejemplares similares
-
Interbilayer-Crosslinked Multilamellar Vesicles as Synthetic Vaccines for Potent Humoral and Cellular Immune Responses
por: Moon, James J., et al.
Publicado: (2011) -
Antigen Delivery by Lipid-Enveloped PLGA Microparticle
Vaccines Mediated by in Situ Vesicle Shedding
por: Hanson, Melissa C., et al.
Publicado: (2014) -
Block Copolymer Micelles as Nanocontainers for Controlled Release of Proteins from Biocompatible Oil Phases
por: Miller, Andrew C., et al.
Publicado: (2009) -
Role of Physicochemical Properties in Nanoparticle Toxicity
por: Shin, Seung Won, et al.
Publicado: (2015) -
Molecular Engineering of Peptide–Drug Conjugates for Therapeutics
por: Fang, Yu, et al.
Publicado: (2022)